Pediatric Solid Tumor Clinical Trials

7 recruiting

Pediatric Solid Tumor Trials at a Glance

14 actively recruiting trials for pediatric solid tumor are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Phase 1 with 6 trials, with the heaviest enrollment activity in Memphis, Guangzhou, and Bethesda. Lead sponsors running pediatric solid tumor studies include St. Jude Children's Research Hospital, National Cancer Institute (NCI), and Institut Claudius Regaud.

Browse pediatric solid tumor trials by phase

Treatments under study

About Pediatric Solid Tumor Clinical Trials

Looking for clinical trials for Pediatric Solid Tumor? There are currently 7 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Pediatric Solid Tumor trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Pediatric Solid Tumor clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 114 of 14 trials

Recruiting

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

Solid TumorPediatric Solid TumorMalignant Solid Tumors+2 more
National Cancer Institute (NCI)10,000 enrolled3 locationsNCT03739827
Recruiting
Phase 1

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

Advanced Breast CancerAdvanced Solid TumorsMetastatic Pancreatic Cancer+3 more
National Cancer Institute (NCI)116 enrolled2 locationsNCT04222413
Recruiting

Tumor-Lymph Node Mapping

SarcomaGerm Cell TumorRhabdomyosarcoma+1 more
University of Rochester10 enrolled1 locationNCT07054944
Recruiting
Phase 1

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Soft Tissue SarcomaMelanomaCarcinoma+13 more
St. Jude Children's Research Hospital48 enrolled1 locationNCT04897321
Recruiting
Phase 1

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

Pediatric Solid TumorPediatric Brain Tumor
Washington University School of Medicine20 enrolled1 locationNCT05521984
Recruiting
Phase 1Phase 2

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Hepatocellular CarcinomaRefractory Solid TumorPediatric Solid Tumor+3 more
St. Jude Children's Research Hospital64 enrolled2 locationsNCT05468359
Recruiting

Dissecting Tumour MicroenvirOnment in Solid Paediatric Tumour to Improve Adoptive Cell Therapy

Pediatric Solid Tumors
Fondazione IRCCS Policlinico San Matteo di Pavia44 enrolled1 locationNCT07240207
Recruiting
Phase 1

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

Pediatric Solid TumorsRefractory/Relapse Neuroblastoma
Kyushu University61 enrolled1 locationNCT05608148
Recruiting

Molecular Analysis Of Solid Tumors

Pediatric Solid Tumors
St. Jude Children's Research Hospital1,000 enrolled1 locationNCT01050296
Recruiting

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

Pediatric Solid TumorEpendymoma of Brain
Institut Claudius Regaud370 enrolled1 locationNCT05151718
Recruiting
Not Applicable

Development and Application of Intervention Program to Improve Mental Health and Quality of Life of Solid Tumor Survivors and Caregivers

Pediatric Solid Tumors
National Cancer Center, Korea120 enrolled3 locationsNCT06969742
Recruiting
Phase 1

UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors

Pediatric Solid Tumor
Sun Yat-sen University39 enrolled1 locationNCT06760117
Recruiting

Liquid Biopsies in Pediatric Solid Tumors

Pediatric Solid Tumor, Unspecified, Protocol Specific
Children's Hospital Los Angeles320 enrolled1 locationNCT05068583
Recruiting
Phase 3

Ondansetron (ODF) Versus Ondansetron Intravenously for the Prevention of Chemotherapy-induced Nausea and Vomiting Compare in Children

Pediatric Solid Tumor, Unspecified, Protocol Specific
Yizhuo Zhang376 enrolled1 locationNCT06208917